|
Pharmacologic Management of Obesity: Improving Health and Reducing Risks in Adolescents and Adults
Course of the Month - March 2023
|
|
Facebook
LinkedIn
E-Mail
|
(3155)
|
Course of the Month March 2023
Each month, the American Association of Nurse Practitioners® (AANP) will offer a continuing education (CE) activity presented by experts from AANP Communities. For the first month that it is offered, the activity will be FREE and only available to AANP members. After the initial month has passed, the activity will become available to both AANP members and non-members for a fee (AANP members will pay a significantly discounted price). The featured activity will rotate each month, so be sure to complete the activity and earn your CE credit before the month ends to benefit from free access! Are you interested in this activity but not yet an AANP member? Becoming an AANP member can help you save on the purchase of this course and others — and it will provide you a full year of access to exclusive member benefits. Learn more about AANP membership and consider becoming a member today!
Promotional Content Expires: | March 31, 2023 (11:55 p.m. CT) | Content Expires: | February 29, 2024 (11:55 p.m. CT) CE for this activity will not be available after this date. |  | This activity includes closed captioning. |
This activity is free for AANP members from 3/1/2023 - 3/31/2023. |
Overview Obesity is a chronic, progressive relapsing disease that requires comprehensive, long-term treatment. When obesity is successfully managed, many of the conditions that NPs routinely treat improve. Pharmacotherapy is a pillar of obesity treatment and can significantly improve outcomes for those living with obesity. In this course you will earn how to identify current medications that may be contributing to excess weight and prescribe appropriate alternatives, as well as how to prescribe current FDA approved anti-obesity medications. Evidence-based pharmacologic management treats the root resulting in improved health, reduced risk, and improved quality of life.
Objectives
- Apply evidence-based guidelines to care for patients with obesity, to include pharmacologic management.
- Identify medication classes that are weight promoting or weight inducing.
- Describe the patient eligibility criteria for FDA-approved anti-obesity medications.
- Identify the available FDA-approved anti-obesity medications, including mechanism of action, contraindications, interactions and adverse effects.
- Describe how to initiate, titrate, and monitor response to medications, including criteria for continuation and discontinuation.
Speaker Nancy Tkacz Browne, MS, PPCNP-BC, FOMA, FAANP, FAAN Sandra Christensen, MSN, ARNP, FNP-BC, FOMA
Disclosure This program was planned in accordance with AANP CE Standards and Policies. Speaker Disclosures:
- Nancy Tkacz Browne has no relevant financial relationships to disclose.
- Sandra Christensen has the following disclosures: Novo Nordisk—Speakers Bureau for Obesity, Eli Lilly—Advisory Board for Obesity.
All relevant relationships have been mitigated.DisclaimerIndividuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- Video Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information For questions or more information concerning this CE Center activity, contact AANP CE Center Support at cecenter@aanp.org.
1.65 Contact Hour(s) of CE, All of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand) At the Heart of the Matter
(OnDemand) Multiple Sclerosis and Covid-19 Vaccination
(OnDemand) Hot Topics In Infectious Disease for the PCP
(OnDemand) Understanding Pelvic Organ Prolapse: Evaluation and Management
(Multi-Module) Addressing Substance Use Disorders in Primary Care Bundle
(OnDemand) Nurse Coaching: The Crucial Tool Missing From the Pain Tool Box
(OnDemand) Head and Neck Cancer Essentials: What NPs Need to Know
(OnDemand) 2023 Update on Treatment of Hypertension in Older Adults (N23)
(OnDemand) Human Trafficking: Nurse Practitioners Leading the Clinical Response
(OnDemand) Module 1: Tobacco Cessation
(OnDemand) Pain Assessment and Management – All That You Didn’t Learn in School (But Wish You Did!) Part 1 and Part 2
(OnDemand) Exhausted at Menopause: Recognition and Treatment Options (N23)
|
|